Associated Papers
The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.
Saifullah M et al.
European Review for Medical and Pharmacological Sciences, 2024
Select a paper to view details